- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04153071
Unipolar Microplasma Radiofrequency Device: In-vivo Histologic Study
Evaluation of the Cutaneous Effects of a Unipolar Microplasma Electrode Pin Radiofrequency Device: An In-vivo Histologic Study
Prospective, Open-Label, Single-Center Pilot Study.
The study is aimed to evaluate the histologic effects of a unipolar microplasma electrode pin radiofrequency device (Alma Lasers OPUS system) on the abdominal skin.
The study will include up to 2 subjects. Each subject will have a single cutaneous treatment of their lower abdomen, with variable treatment parameters. Punch biopsies will be obtained from each treatment section, for in-vivo histological evaluations.
Study Overview
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Austin, Texas, United States, 78746
- Westlake Dermatology Clinical Research Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subject seeking surgical correction of abdominal tissue laxity with an abdominoplasty within the subsequent 1-12 months.
- Subject abdominal skin must be of appropriate quality to allow for proper study treatment, as judged by the Investigator.
- The subject must be willing to have punch biopsy specimens obtained from all treated areas following treatment.
- The Subject must sign a statement of informed consent to the Investigator and Sponsor.
Exclusion Criteria:
- The subject is less than 18 or greater than 75 years of age.
- Subject with excessive superficial skin laxity and/or striae of the abdomen, which would prevent proper study treatment.
- A subject that is unwilling to have punch biopsy specimens obtained from treated areas.
- Subject with a history of allergy to lidocaine or epinephrine.
- Known history of keloids or bleeding/coagulation disorder.
- Presence of surgical or non-surgical scars in the area to be treated.
- Active inflammatory or infectious process or any other active or serious skin disease in the area to be treated.
- Planned surgical procedures with incisions and suturing in the area to be treated during the course of the study.
- Subjects who have had (or plan to have during the course of the study) an abdominal skin treatment with any exclusionary treatments, medications, and/ or devices.
- Subjects who have used oral isotretinoin or other oral retinoids during the study in the prior 12 months or planning to be on them during the course of the study.
- Subjects receiving antiplatelet, anticoagulant, or non-steroidal anti-inflammatory agents within 2 weeks of treatment, or planning to receive during the course of the study; in whom, in the Investigator's opinion, administration of radiofrequency treatment may cause procedure-related complications.
- Women who are pregnant, nursing or intend to become pregnant over the duration of the study, or women who are of childbearing potential not protected by an effective contraceptive method of birth control. Pregnancy status should be checked by urine testing at baseline (Day 0).
- Subjects who are unwilling or unable to give written consent to participate in the study or unable to comply with the requirements of the clinical trial protocol.
- Subjects who have received an experimental drug or device within the previous 3 months prior to enrollment.
- Subjects who are known as alcohol or drug abusers.
- Subjects who are suffering from any physical or psychological condition, or are under treatment for any such condition which, in the opinion of the Investigator, may constitute an unwarranted risk or which may affect the subjects' compliance or adherence to study procedures.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Unipolar microplasma RF treatment
Single cutaneous unipolar microplasma RF treatment, with variable treatment parameters
|
Each subject will have a single cutaneous treatment of their lower abdomen, with variable treatment parameters.
Punch biopsies will be obtained from each treatment section, for in-vivo histological evaluations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diameter and depth of ablation and/or coagulation from varying RF device treatment parameters
Time Frame: Immediately post treatment
|
Histology analysis to evaluate the diameter and depth of ablation and/or coagulation from varying microplasma RF device treatment parameters, based on biopsy specimens
|
Immediately post treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of adverse events
Time Frame: 10 days
|
Safety will be monitored by documentation of adverse events
|
10 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Daniel Friedmann, MD, FAAD, Westlake Dermatology Clinical Research Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ALM-OPUS-19-010
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Resurfacing
-
Syneron MedicalCompletedSkin Resurfacing | Wrinkle ReductionUnited States, Canada
-
Navamindradhiraj UniversityCompletedOnlay Patellar Resurfacing Technique | Inlay Patellar Resurfacing Technique | Patellar ResurfacingThailand
-
Zimmer BiometBiomet France SARLCompletedTotal Hip ResurfacingFrance
-
Novoxel Ltd.CompletedWrinkle | Periorbital | Tixel 2 | Fractional | ResurfacingUnited States, Israel
-
The Catholic University of KoreaUnknownOsteoarthritis, Patella Resurfacing
-
Navamindradhiraj UniversityActive, not recruitingRemoval of Fibrosynovial Tissue | Non-removal of Fibrosynovial Tissue | Patellar Non-resurfacingThailand
-
Navamindradhiraj UniversityCompletedPatellar Resurfacing | Patellar Denervation | Non-patellar DenervationThailand
-
PharmanexCompletedSkin Elasticity | Beauty Drink Powder | Cosmetic Apparatus on Skin | Skin Dryness | Skin Moisture | Skin Evenness | Skin FirmnessChina
-
West Virginia UniversityMary Babb Randolph Cancer Center at West Virginia University Hospitals; West...RecruitingSkin Cancer | Skin Lesion | Skin Melanoma | Tumor SkinUnited States
-
Medical University of ViennaUnknownNon-melanocytic Skin Tumors | Melanocytic Skin TumorsAustria
Clinical Trials on OPUS system
-
University of CopenhagenAarhus University Hospital; Medical Research Council; Region Capital Denmark; Mental...CompletedPsychotic Disorders | Schizophrenia | Schizoaffective Disorder | First Episode Psychosis of Schizophrenia and Schizotypal DisorderDenmark
-
Mental Health Services in the Capital Region, DenmarkRecruitingSchizophrenia | Schizoaffective Disorder | Delusional Disorder | Depression Severe | Schizotypal Disorder | Acute and Transient Psychotic Disorder, Unspecified | Non-Organic Psychosis | Substance Induced PsychosesDenmark
-
Rigshospitalet, DenmarkUniversity of Copenhagen; Mental Health Services in the Capital Region, DenmarkCompletedPsychotic Disorders | Schizophrenia | Schizoaffective Disorder | Schizotypal Disorder | First Episode PsychosisDenmark
-
Erasmus Medical CenterCompletedHIV/AIDS | Opportunistic Infections, HIV RelatedNetherlands
-
Mental Health Services in the Capital Region, DenmarkEnrolling by invitationSchizophrenia Spectrum and Other Psychotic DisordersDenmark
-
ResMedCompleted
-
Federal University of São PauloCompletedAdverse Reaction to Systemic AgentsBrazil
-
KineticureCompletedOsteoarthritis | Knee PainUnited States
-
Smith & Nephew, Inc.CompletedDiabetic Foot Ulcers | Venous Leg UlcersUnited States, Canada